Singapore
Every company in the roster headquartered in Singapore.
Every company in the roster headquartered in Singapore.
5 of 5 companies
| Company | Pipeline | Most advanced | Next readout | Market cap | Cash & inv. | Runway | R&D / yr |
|---|---|---|---|---|---|---|---|
Adlai Nortye Biopharma Co., Ltd.ANL · Nasdaq | 1 asset: 1 Ph 2 | PalupiprantPhase 2 · Non-Small Cell Lung CancerWeak signal | None on record | $350M | $61MDec 2024 | Ended Mar 2026 | $45M |
Aeira Pte. Ltd.Private | 1 asset: 1 Ph 3 | stapokibartPhase 3 · Atopic DermatitisReliable signal | Feb 2027stapokibart · Phase 3 | — | — | — | — |
| 1 asset: 1 Ph 3 | TricaprilinPhase 3 · Alzheimer's DiseasePartial signal | Jan 2030Tricaprilin · Phase 3 | — | — | — | — | |
Hummingbird BiosciencePrivate | 2 assets: 2 Ph 2 | NezutatugPhase 1/2 · Non-Small Cell Lung CancerWeak signal | Jul 2027ENV-501 · Phase 1/2 | — | — | — | — |
Moleac Pte LtdPrivate | 1 asset: 1 Ph 3 | MLC901Phase 3 · Alzheimer's Disease | Feb 2029MLC901 · Phase 3 | — | — | — | — |
Next readout: the earliest estimated primary completion of a trial the company or a partner on the asset runs (ClinicalTrials.gov). Cash shows its balance-sheet month; runway shows a month only when it comes from an earlier report.